Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
Recruiting · NCT05780684 · Registry updated 2026-06-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not applicable | 2026-06-22 | NCT05780684 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dartmouth-Hitchcock Medical Center | 104 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dartmouth-Hitchcock Medical Center | Lebanon | United States | 86 |